Nalbuphine hydrochloride
Active substance: nalbuphine
INJECTION · NALBUPHINE HYDROCHLORIDE 10 mg/mL
United StatesActive
Marketing holder: Somerset Therapeutics, LLC
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
- NALBUPHINE HYDROCHLORIDE · 10 mg/mL
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 6 |
|
Control by country
- RussiacontrolledSchedule: ПIII
Source: GRLS (Russian state register) · record 01a120c3-2cd6-7950-8b5f-c1c6302caec2,01a120c3-7195-7ba4-916d-b95bd13c40ec,01a120c4-09ff-74a0-9e05-ce290fe3d0dd,01a120c4-24b0-7bfe-8ab5-b7439d3f961e,01a120c5-388c-7019-9a6f-72919b5d2147;count=6 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-277a-7927-bc5a-3a6541862423,01a1208c-b3d8-7326-85df-98a2b97ecfb3,01a1208d-9ff6-7eda-9058-ca010563b60d,01a1208d-a7b2-7224-abbe-698615a66193,01a1208d-afb6-7869-905e-809d1d3d0682;count=17 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 70069-671
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
- product · openFDA NDC · 70069-671 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 70069-671 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 70069-671 · Verified 2026-10-09 · open in source